BioCentury | Oct 3, 2019
Financial News

OrbiMed-led $80M series B to help Adicet bring its γδ cell therapies to the clinic

...Ltd., Consensus Business Group, SBI JI Innovation Fund, Samsung Venture Investment Corp., Handok Inc. and DSC Investment...
BioCentury | Nov 7, 2018
Emerging Company Profile

ABL bispecifics

...of employees: 45 Funds raised: $95 million Investors: AlpenRoute Asset Management, Comes Investment, DS Asset, DSC Investment...
BioCentury | May 18, 2018
Finance

China comes to Europe

...Eloxx Pharmaceuticals Ltd. (Israel) (B) $38.0 Series C Catalyst Ventures, LSP, Pontifax, Korea Investment Partners, DSC Investment...
BioCentury | Dec 21, 2015
Financial News

Kahr Medical completes venture financing

...2015-12-15 Type: Venture financing Raised: $12 million Investors: Korea Investment Partners; Mirae Asset Venture Investment; DSC Investment...
Items per page:
1 - 4 of 4
BioCentury | Oct 3, 2019
Financial News

OrbiMed-led $80M series B to help Adicet bring its γδ cell therapies to the clinic

...Ltd., Consensus Business Group, SBI JI Innovation Fund, Samsung Venture Investment Corp., Handok Inc. and DSC Investment...
BioCentury | Nov 7, 2018
Emerging Company Profile

ABL bispecifics

...of employees: 45 Funds raised: $95 million Investors: AlpenRoute Asset Management, Comes Investment, DS Asset, DSC Investment...
BioCentury | May 18, 2018
Finance

China comes to Europe

...Eloxx Pharmaceuticals Ltd. (Israel) (B) $38.0 Series C Catalyst Ventures, LSP, Pontifax, Korea Investment Partners, DSC Investment...
BioCentury | Dec 21, 2015
Financial News

Kahr Medical completes venture financing

...2015-12-15 Type: Venture financing Raised: $12 million Investors: Korea Investment Partners; Mirae Asset Venture Investment; DSC Investment...
Items per page:
1 - 4 of 4